Insulin Pumps

We are happy to announce that the 5th edition of Pumping Insulin is finally at the printers! Books will be shipped to all of our preorder customers in the first week of June. If you haven't ordered yet, order today for only $19.55

Pumping Insulin 5th Edition provides up-to-date information on how to use the smart pump for the best blood glucose management.

Insulet and Johnson & Johnson announced an agreement to incorporate the OneTouch technology into the Omnipod's remote controller. The next Omnipod will have a built in blood glucose meter in the PDM, allowing you to carry one less device. Insulet already has a deal with Abbott Diabetes Care to include their Freestyle technology in their new PDM but the deal isn't exclusive. Upon release, Insulet could decide to have a separate device for each blood glucose meter technology or switch to Lifescan exclusively after the Abbott deal expires in 2013.

DexCom and Tandem Diabetes Care have a CGM Development and Commercialization Agreement to integrate the Dexcom's future generation sensor into the t:slim Insulin Delivery System. The t:slim, the first touch-screen insulin pump, has FDA approval but is not on the market yet. The announcement also mentions "future generations of the sensor", so it may be awhile before we see the systems actually working together.

Tandem Diabetes Care, Inc. received U.S. Food and Drug Administration (FDA) approval on 11/16/11 to market the t:slim Insulin Delivery System. The t:slim is one of the first insulin pumps to be cleared under the FDA’s new Infusion Pump Improvement Initiative. It has a revolutionary pump system powered by pressure with a microdosing mechanism that can deliver doses as small as 0.001 u.

Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.

Here's an excerpt from the announcement:

The SOLO MicroPump Insulin Delivery System is a patch pump originally made by Medingo and purchased by Roche in 2010. Solo received FDA approval in 2009 and is expected to be available in 2012. The system has 4 parts: a micropump composed of reusable electronics plus an insulin reservoir, a remote, and a cradle.

The Debiotech JewelPump is a disposable patch pump with some similarities to the current Omnipod, as well as other patch pumps on the horizon. Debiotech, a Swiss company, teamed with ST Microelectronics to create this sleek pump system. Like most patch pumps, a separate controller is required to deliver bolus insulin doses. It use a microelectromechanical (MEMS) pumping system, that allows the pump to be kept small and light.

The Cellnovo semi-patch pump (patch pump with a nearby infusion site) got a lot of attention in 2009 when it was first announced because of it's small size and iPhone like handset. Cellnovo, a London based company, has now joined forces with Osaka, Japan based Nipro Diagnostics, a blood glucose meter company, for integration of a meter into the Cell-Novo controller for the pod.

The MiniMed Paradigm Revel System is their second generation integrated system. The system is setup to work as a standard insulin pump or with the Medtronic Continuous Glucose Monitor (CGM). The 2 devices communicate wirelessly.

SUNNYVALE, Calif., May 17, 2011 – Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements.